SBN 0.00% 0.0¢ sun biomedical limited

stock at hand

  1. gsw
    4,920 Posts.
    Point of Interest.

    According to the update, stock at hand, was valued at $105,000 (cost to the company) an increase of $55,000.

    Given that the sale cost of the product to the distributors is around, $4.70 per unit, ie, $282,000 divided by 59,111 units.

    And assuming that the cost to the company of producing that unit is approximately half, it means that, according to my calculations, there are approximately 40,000 to 45,000 units in stock.

    Now most business would prefer to only carry stock sufficient for a max of 2 weeks and therefore they are either over manufacturing or sales this quarter have increased dramatically.

    Let's assume that they are carrying one months inventory.

    45,000 units, therefore multiplied by 3 gives me units expected to be sold in this current quarter as 135,000 multiplied by $4.70 per unit equals Total sales for the current quarter of $634,500.

    And that's my prediction for sales at the end of the June quarter and therefore reaching cash flow positive.



 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.